Atabak Mokari has sold CORT and made no open-market buys since Jun 2026

Atabak Mokari is an individual and serves as Chief Financial Officer and Treasurer of Corcept Therapeutics Incorporated. Corcept’s SEC appointment agreement identifies him as joining the company in the CFO role, and later insider-trading disclosures confirm he remained the company’s CFO in 2026.(

Public profile sources describe Mokari as a finance executive with responsibility for Corcept’s financial leadership, including treasury-related duties, and note that his professional background, career history, and education are tracked in executive databases such as Bloomberg and GuruFocus.( In June 2026, he reported a pre-arranged Rule 10b5-1 transaction in which he exercised options for 40,000 shares and sold the same number, a routine compensation-related insider transaction rather than a discretionary open-market purchase.(

Written by Perplexity from public sources.